Comparison of Breast Pump Suction Patterns

September 2, 2025 updated by: University of Florida

Comparison of Breast Pump Suction Patterns in Achievement of Coming to Volume in Breast Pump-Dependent Mothers of Critically Ill Infants

Compare effectiveness of breast pump patterns on lactation outcomes of pump dependent mothers of critically ill infants

Study Overview

Status

Completed

Detailed Description

Insufficient Mothers Own Milk (MOM) has its origins during the first 14 days postpartum, a critical window that includes secretory activation (SA; milk coming in; lactogenesis II) and the achievement of coming to volume (CTV; providing 500 mLs/day of MOM by day 14 postpartum). For all lactating mothers, SA must be achieved for lactation to continue, and CTV predicts provision of MOM through to neonatal intensive care unit (NICU) discharge in preterm very low birth weight (VLBW; <1500 g birth weight) infants. For this study, we posit that alternate breast pump suction patterns (BPSP; suction rate, intensity, and rhythm) may facilitate achievement of CTV in mothers who have achieved SA, but whose daily pumped MOM volumes indicate a high risk of not achieving CTV. Therefore, the overall objective of this study is to compare the clinical effectiveness of three different breast pump suction patterns on lactation outcomes, including achievement of SA, among pump dependent mothers of critically ill infants who demonstrate faltering lactation after achievement of SA. At 6-8 days postpartum, 90 pump dependent mothers of critically ill infants who have achieved SA but demonstrate faltering lactation (<350 mLs/day pumped MOM volume), will be randomized to use one of three different BPSPs with two groups having alternative BPSPs and one group using the current practice standard for 7 days.

Study Type

Interventional

Enrollment (Actual)

96

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Florida
      • Gainesville, Florida, United States, 32504
        • Neonatal intensive care unit at Shands children's hospital at the Univeristy of Florida

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • > 18 years of age
  • delivered an infant admitted to the NICU
  • Intent to provide exclusive mother's own milk to their infants for the first 14 days postpartum
  • Expect to be breast pump dependent for the first 14 days postpartum

Exclusion Criteria:

  • Breast reduction or augmentation
  • Infant not expected to survive
  • Medications or maternal conditions incompatible with providing mother's own milk to a NICU infant
  • Resides over 60 miles from University of Florida (UFHealth) in Gainesville, FL.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Sequential Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Breast Pump Suction Pattern 1
Mothers who have reached secretory activation and are pumping <350 mLs/day will be randomized to one of three breast pump suction patterns.
Active Comparator: Breast Pump Suction Pattern 2
Mothers who have reached secretory activation and are pumping <350 mLs/day will be randomized to one of three breast pump suction patterns.
Sham Comparator: Breast Pump Suction Pattern 3
Mothers who have reached secretory activation and are pumping <350 mLs/day will be randomized to one of three breast pump suction patterns.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pumped milk volume
Time Frame: Days 1-15 post-partum
Daily volume of milk pumped daily
Days 1-15 post-partum

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maintenance of secretory activation
Time Frame: Days 1-15 post-partum
Whether sodium level < 20 is maintained
Days 1-15 post-partum
Maternal perceptions of comfort, effectiveness, efficiency, and convenience
Time Frame: Day 15 post-partum
Survey will be used to collect mother's perception of comfort, efficiency, and convenience
Day 15 post-partum
Proportion of infant feeds consisting of mother's own milk .
Time Frame: Days 1 post-partum until 6 months .
Proportion of feeds consisting of mother's own milk for first 15 days, infant discharge, as well as 3 and 6 months
Days 1 post-partum until 6 months .

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Leslie Parker, PhD, University of Florida

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2024

Primary Completion (Actual)

December 30, 2024

Study Completion (Actual)

December 30, 2024

Study Registration Dates

First Submitted

September 25, 2023

First Submitted That Met QC Criteria

September 25, 2023

First Posted (Actual)

September 29, 2023

Study Record Updates

Last Update Posted (Estimated)

September 3, 2025

Last Update Submitted That Met QC Criteria

September 2, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 202202805

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Insufficient Breast Milk Syndrome

Clinical Trials on Breast Pump suction pattern

Subscribe